首页> 外文期刊>Cancer Management and Research >Sinonasalasopharyngeal pleomorphic adenoma and carcinoma ex pleomorphic adenoma: a report of 17 surgical cases combined with a literature review
【24h】

Sinonasalasopharyngeal pleomorphic adenoma and carcinoma ex pleomorphic adenoma: a report of 17 surgical cases combined with a literature review

机译:鼻/鼻咽多形性腺瘤和癌前多形性腺瘤:17例外科手术报道并结合文献复习

获取原文
       

摘要

Objective: The aim of this study was to review demographic data, location, clinical symptoms, therapeutic methods, pathological features and relapse in sinonasalasopharyngeal pleomorphic adenoma (PA) and carcinoma ex pleomorphic adenoma (CXPA). Methods: We conducted a retrospective analysis of 17 patients who were referred to our hospital during a 5-year period from 2013 to 2018. Results: In this series, there were 7 males and 10 females. The tumors originated from the nasal septum in 4 cases, from the lateral wall of the nasal cavity in 2 cases, from the maxillary sinus in 1 case, and from the nasopharynx in 7 cases. The origin sites of 3 cases were not clear. The main symptoms were usually unilateral nasal congestion and epistaxis. All patients underwent endoscopic resection surgery. The postoperative period was uneventful. Ten patients were diagnosed with benign PA, and 7 patients were diagnosed with CXPA, including 5 cases of adenocarcinoma, 1 patient with mucoepidermoid carcinoma, and 1 patient with adenoid cystic carcinoma. After a mean follow-up period of 2.2 years (6 months–5.3 years), the recurrence rate of benign PA was 10% (1/10); the rate of malignant recurrence was 42.8% (3/7). Conclusion: Sinonasalasopharyngeal PA and CXPA are rare neoplasms, and the most common primary site of PA and CXPA is the nasopharynx. As any salivary carcinoma type can arise in PA, these PA sites should be thoroughly sampled and closely examined to exclude the possibility of malignant transformation. Furthermore, PA and CXPA should be treated as soon as possible after definitive diagnosis, and endoscopic resection of tumor-negative margins may be helpful in preventing recurrence.
机译:目的:本研究的目的是回顾鼻窦/鼻咽多形性腺瘤(PA)和癌前多形性腺瘤(CXPA)的人口统计学数据,位置,临床症状,治疗方法,病理特征和复发情况。方法:我们对2013年至2018年的5年内转诊至我院的17例患者进行了回顾性分析。结果:在该系列中,男7例,女10例。肿瘤起源于鼻中隔4例,鼻腔侧壁2例,上颌窦1例,鼻咽7例。 3例病例的起源部位不清楚。主要症状通常是单侧鼻充血和鼻epi。所有患者均接受内镜切除手术。术后期间平稳。诊断为良性PA 10例,诊断为CXPA 7例,其中腺癌5例,黏液表皮样癌1例,腺样囊性癌1例。在平均随访2.2年(6个月至5.3年)后,良性PA的复发率为10%(1/10)。恶性复发率为42.8%(3/7)。结论:鼻/鼻咽PA和CXPA是罕见的肿瘤,PA和CXPA最常见的原发部位是鼻咽。由于PA中可能会出现任何唾液癌类型,因此应对这些PA部位进行彻底取样并仔细检查,以排除恶性转化的可能性。此外,在明确诊断后应尽快治疗PA和CXPA,并且内镜切除肿瘤阴性切缘可能有助于预防复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号